Skip to evidence report

GRNLSA.p53_damage: Studies — page 10

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 297 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 9,001–10,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for GRNLSA.p53_damage
#Trait / studyIndividual trait IDMean IC score
9001Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T258ECGU0002589.40e-03
9002Hip indexGCST0122299.38e-03
9003Abdominal subcutaneous adipose tissue volumeGCST900166729.38e-03
9004Creatinine levelsGCST904972379.36e-03
9005Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T483ECGU0004839.35e-03
9006Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T231ECGU0002319.33e-03
9007CholecystitisFING000002749.33e-03
9008HMOX2 levelsGCST904694669.30e-03
9009systolic blood pressure (SBP, mean, inv-normal transformed)GCST904764039.29e-03
9010Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T238ECGU0002389.27e-03
9011Frontal QRS-T angleGCST902463219.24e-03
9012wg rh intensity-contrast fusiformGCST900038339.24e-03
9013IL22 levelsGCST904695829.23e-03
9014Left-hemisphere control network to putamen white-matter structural connectivityGCST903027549.21e-03
9015Chronic hepatitis B infectionGCST900185849.20e-03
9016CCL19 levelsGCST902747659.16e-03
9017Biological Mother: Cancer, BreastGCST904754859.16e-03
9018HDGF levelsGCST904694429.13e-03
9019GSTT2 levelsGCST900866529.11e-03
9020Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T475ECGA0004759.11e-03
9021Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T491ECGU0004919.11e-03
9022ELOA/MAD1L1 ratioGCST903146409.05e-03
9023Cervicalgia (PheCode 761)GCST904762679.04e-03
9024Left-hemisphere visual network to right-hemisphere control network white-matter structural connectivityGCST903026609.04e-03
9025Deforming dorsopathiesFING000003859.02e-03
9026BA-exvivo rh volume BA4aGCST900028539.02e-03
9027Soya milk likingGCST900948459.00e-03
9028Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T408ECGA0004088.98e-03
9029PROK2 levelsGCST906170738.97e-03
9030PDIA4 levelsGCST904701958.96e-03
9031Autorefraction - 6mm strong meridian (left) | EyesightUKBB000000758.95e-03
9032NTF3 levelsGCST904700948.92e-03
9033wg lh intensity-contrast parahippocampalGCST900038078.89e-03
9034Brainstem global volume PonsGCST900027658.87e-03
9035Nerve, nerve root and plexus disordersFING000008628.87e-03
9036Genital prolapse | genitourinaryUKBB000002828.87e-03
9037Hearing loss (PheCode 389)GCST904759098.82e-03
9038neutrophil (absolute count, mean, inv-norm transformed)GCST904755298.79e-03
9039HippSubfield rh volume subiculum-bodyGCST900026918.79e-03
9040T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 40)GCST903208598.76e-03
9041CD101 levelsGCST904685968.76e-03
9042ARHGAP25 levelsGCST902426518.73e-03
9043SIT1 levelsGCST904706448.72e-03
9044Acquired foot deformities (PheCode 735)GCST904762478.69e-03
9045Glycine levelsGCST904973168.68e-03
9046DTI autoptx FA ptr l tractGCST903851318.67e-03
9047aparc-a2009s lh volume S-circular-insula-supGCST900029738.61e-03
9048Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T215ECGA0002158.60e-03
9049Posterior diffusion tensor imaging along the perivascular space indexGCST904555458.59e-03
9050Other diseases of intestinesFING000010018.57e-03
9051ST6GAL1 levelsGCST904707538.55e-03
9052Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T404ECGA0004048.54e-03
9053T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 110)GCST903209298.52e-03
9054Other diseases of the respiratory systemFING000010118.51e-03
9055Bell pepper likingGCST900947038.51e-03
9056Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T261ECGU0002618.47e-03
9057CCR2 on CD14+ CD16- monocyteGCST900020048.45e-03
9058Left-hemisphere default mode network to amygdala white-matter structural connectivityGCST903027728.45e-03
9059Cancer of prostate (PheCode 185)GCST900418538.44e-03
9060Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T239ECGU0002398.43e-03
9061MIF levelsGCST900890188.42e-03
9062Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T419ECGA0004198.41e-03
9063Hair/balding pattern: Pattern 4 (UKB data field 2395_4)GCST900436198.40e-03
9064IDP T1 FAST ROIs R cerebellum VIIbGCST900025778.39e-03
9065Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T413ECGA0004138.36e-03
9066Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T412ECGA0004128.36e-03
9067Retinal detachment with retinal breakFING000012598.35e-03
9068MMP8/TGFA ratioGCST903154668.34e-03
9069DNPH1/PDGFB ratioGCST903145278.34e-03
9070Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levelsGCST902000138.33e-03
9071Principal component-derived dietary pattern 58GCST901330618.33e-03
9072C1QTNF1 levelsGCST904684888.32e-03
9073aparc-a2009s lh area G-cuneusGCST900033078.30e-03
9074Trigger fingerFING000013768.29e-03
9075Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T406ECGA0004068.28e-03
9076Other disorders of skin and subcutaneous tissueFING000010358.26e-03
9077AIF1 levelsGCST904682678.20e-03
9078wg rh intensity-contrast rostralanteriorcingulateGCST900038528.18e-03
9079MESD/WWP2 ratioGCST903154268.18e-03
9080Basophil percentage of white cellsGCST900023808.16e-03
9081Atrial fibrillation and flutter (PheCode 427.2)GCST904759678.15e-03
9082Retinal thickness (functional principal component 1)GCST904557218.14e-03
9083Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T414ECGA0004148.13e-03
9084Deaf mutism, not elsewhere classifiedFING000003788.13e-03
9085potassium (mean, inv-norm transformed)GCST904763078.10e-03
9086Synovitis and tenosynovitis (PheCode 727.1)GCST904762428.09e-03
9087PTGDS levelsGCST904703688.08e-03
9088NXF1 levelsGCST902421498.06e-03
9089MME levelsGCST904699148.06e-03
9090PTPN1/WWP2 ratioGCST903157468.04e-03
9091COLEC12/OGN ratioGCST903141848.04e-03
9092Female infertilityFING000005368.03e-03
9093RGS18 levelsGCST902426178.02e-03
9094DTI TBSS L3 Uncinate fasciculus RGCST903845687.99e-03
9095ThalamNuclei lh volume CMGCST900027187.95e-03
9096T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121)GCST903209407.94e-03
9097IDP T1 FIRST left caudate volumeGCST900024387.91e-03
9098SCAMP3/STX4 ratioGCST903158057.90e-03
9099Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)FING000008467.89e-03
9100Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T232ECGA0002327.88e-03
9101ZBTB17 levelsGCST904710967.87e-03
9102T1 FIRST volume R PutaGCST903839957.87e-03
9103PLXNA4/SRPK2 ratioGCST903156887.86e-03
9104Chronic obstructive pulmonary disease liability (machine learning-based score)GCST902440987.86e-03
9105FAM174A levelsGCST902419147.85e-03
9106XXYLT1 levelsGCST902433707.82e-03
9107Eye conditions (confirmatory factor analysis Factor 25)GCST903093597.80e-03
9108Depression/anxiety (weighted GWA)GCST902672777.80e-03
9109Urine 16a-hydroxy DHEA 3-sulfate levels in chronic kidney diseaseGCST902643297.79e-03
9110mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)GCST904754447.78e-03
9111CEP43 levelsGCST904687157.78e-03
9112Autorefraction - 6mm strong meridian (right) | EyesightUKBB000000767.78e-03
9113Testosterone levels (UKB data field 30850)GCST904681037.77e-03
9114CLC levelsGCST904687627.76e-03
9115CXCL16 levelsGCST904689287.69e-03
9116DNAJC6 levelsGCST904690177.66e-03
9117Other dorsopathies, not elsewhere classifiedFING000010417.66e-03
9118T1 CAT volume L TemporalOccipitalFusiformCortexGCST903840767.66e-03
9119Fracture of femurFING000005527.65e-03
9120Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T62ECGU0000627.65e-03
9121Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T411ECGA0004117.62e-03
9122Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T270ECGA0002707.62e-03
9123LYN/YES1 ratioGCST903153517.59e-03
9124Aspartate aminotransferase levelsGCST900187247.58e-03
9125wg lh intensity-contrast insulaGCST900038267.57e-03
9126Blood cell traits latent factor 12 (red cell)GCST905592547.57e-03
9127Exposure to tobacco smoke outside home | SmokingUKBB000002297.56e-03
9128RGMB levelsGCST904704647.55e-03
9129Mean platelet volume during the postpartum periodGCST903022337.52e-03
9130NUDT5/RWDD1 ratioGCST903155807.51e-03
9131Intraocular pressureGCST0040747.49e-03
9132HeterophoriaFING000006207.47e-03
9133Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T420ECGA0004207.46e-03
9134Mononeuropathies of upper limb | Nerve, nerve root and plexus disordersUKBB000004817.45e-03
9135Polyunsaturated fatty acid levelsGCST905026237.45e-03
9136CDC26 levelsGCST904686637.45e-03
9137T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 47)GCST903208667.45e-03
9138HAO1 levelsGCST904694297.43e-03
9139Lung function (FVC)GCST0074297.40e-03
9140TFF3 levelsGCST904708377.39e-03
9141RSPO3 levelsGCST904705047.39e-03
9142DTI TBSS MO Medial lemniscus LGCST903846297.35e-03
9143LRIG3 levelsGCST904697957.34e-03
91441-palmitoyl-2-linoleoyl-GPC (16:0/18:2) metabolite levelGCST906164057.32e-03
9145DTI TBSS FA External capsule LGCST903844137.30e-03
9146Other enthesopathiesFING000010457.30e-03
9147Transient ischemic attackFING000013757.29e-03
9148Hand grip strength (baseline)GCST905658457.28e-03
9149Lichen ruber planus, wide definition including periferal and oral lichen planusFING000007227.27e-03
9150Brainstem global volume Whole-brainstemGCST900027687.26e-03
9151SEZ6L levelsGCST904706077.25e-03
9152Gastrointestinal issues (confirmatory factor analysis Factor 31)GCST903093657.25e-03
9153DAG1/PLA2G4A ratioGCST903143807.22e-03
9154UrolithiasisGCST900187157.22e-03
9155Other and/or unspecified nontoxic goitreFING000009587.20e-03
91561-stearoyl-2-docosahexaenoyl-gpc (18:0/22:6) levelsGCST902000467.19e-03
9157Atrial fibrillation (PheCode 427.21)GCST904759707.19e-03
9158Eosinophil percentage of white cellsGCST0046007.17e-03
9159SpermatoceleFING000013197.17e-03
9160MMP12 levelsGCST900120707.15e-03
9161wg rh intensity-contrast caudalmiddlefrontalGCST900038307.13e-03
9162Left-hemisphere default mode network to accumbens white-matter structural connectivityGCST903027737.13e-03
9163Volume of right cortico-amygdaloid transition areaGCST904750187.11e-03
9164Gamma-glutamylglycine levelsGCST901997417.09e-03
9165DTI TBSS L1 Posterior limb of internal capsule RGCST903844467.08e-03
9166Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T422ECGA0004227.08e-03
91675alpha-pregnan-3beta,20alpha-diol disulfate levelsGCST901998387.08e-03
9168DFFA/SIRT2 ratioGCST903144627.06e-03
9169Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T206ECGA0002067.05e-03
9170Urbanicity (confirmatory factor analysis Factor 4)GCST903093397.04e-03
9171Aplastic anemiaGCST900185747.03e-03
9172Cod likingGCST900947367.03e-03
9173Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T125ECGA0001257.01e-03
9174Sensorineural hearing loss (PheCode 389.1)GCST904759117.01e-03
9175aparc-a2009s lh volume S-postcentralGCST900029916.98e-03
9176IL27 levelsGCST904690606.93e-03
9177MigraineGCST904681426.92e-03
9178BA-exvivo rh volume BA45GCST900028576.88e-03
9179Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T213ECGA0002136.88e-03
9180Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T126ECGA0001266.87e-03
9181Obesity related asthmaFING000008976.87e-03
9182Glaucoma suspectFING000005796.86e-03
9183Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T163ECGU0001636.85e-03
9184Reason for glasses/contact lenses - For 'astigmatism' | EyesightUKBB000007336.83e-03
9185Autorefraction - 3mm cylindrical power angle (left) | EyesightUKBB000000646.81e-03
9186FCAMR levelsGCST904691966.79e-03
9187aparc-a2009s lh volume G+S-subcentralGCST900029286.77e-03
9188Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T61ECGU0000616.75e-03
9189aparc-pial lh area cuneusGCST900031456.75e-03
9190Mean platelet (thrombocyte) volume | Blood countUKBB000004506.73e-03
9191Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T476ECGU0004766.73e-03
9192Pancreas iron contentGCST900166766.72e-03
9193Bread type: Wholemeal/wholegrain vs white and brown (UKB data field 1448)GCST901329686.72e-03
9194RNASE4 levelsGCST904704786.71e-03
9195Other diseases of blood and blood-forming organs, wideFING000009996.71e-03
9196T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 115)GCST903206786.71e-03
9197MNDA/NCF2 ratioGCST903154726.70e-03
9198TNFRSF13C levelsGCST904709066.69e-03
9199SnoringGCST0097626.66e-03
9200Shoulder width to body height ratioGCST902702616.65e-03
9201Fasciitis (PheCode 728.7)GCST904762446.62e-03
9202TPP1 levelsGCST904709466.62e-03
9203Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T214ECGA0002146.62e-03
9204aparc-DKTatlas rh area cuneusGCST900032686.59e-03
9205Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T410ECGA0004106.58e-03
9206LYN/SIRT2 ratioGCST903153496.58e-03
9207Juvenile rheumatoid arthirtisFING000007066.56e-03
9208CLEC1B/PLXNA4 ratioGCST903141006.56e-03
9209CST3/TAFA5 ratioGCST903142986.55e-03
9210T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 28)GCST903208476.54e-03
9211HBEGF levelsGCST902413926.53e-03
9212T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 66)GCST903208856.49e-03
9213KLK1 levelsGCST904697026.49e-03
9214Pre-eclampsia or poor fetal growthFING000012026.48e-03
9215Amyotrophic lateral sclerosisGCST900271646.44e-03
9216Spondylosis and allied disorders (PheCode 721)GCST904762356.42e-03
9217TEX101 levelsGCST904708326.41e-03
9218CST3 levelsGCST904688946.41e-03
9219Autorefraction - 3mm weak meridian (left) | EyesightUKBB000000696.39e-03
9220REST UKBBICA NODEamps25 0021GCST903855046.38e-03
9221NOTCH2 levelsGCST904700666.37e-03
9222potassium (maximum, inv-norm transformed)GCST904763046.36e-03
9223wg lh intensity-contrast superiorparietalGCST900038206.35e-03
9224GonarthrosisFING000005856.34e-03
9225DiverticulitisGCST904681256.34e-03
9226DAG1/PDGFA ratioGCST903143786.34e-03
9227T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 108)GCST903209276.33e-03
9228Eye problems/disorders - Glaucoma | EyesightUKBB000002316.32e-03
9229Incisional hernia (PheCode 550.6)GCST904760646.30e-03
9230aparc-Desikan rh thickness GlobalMeanThicknessGCST900034796.29e-03
9231CAMK1D levelsGCST902405566.28e-03
9232INPP5J levelsGCST904696186.27e-03
9233T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 62)GCST903206256.26e-03
9234wg lh intensity-contrast posteriorcingulateGCST900038146.24e-03
9235Apple juice likingGCST900946906.22e-03
9236DTI autoptx L3 unc r tractGCST903852196.22e-03
9237Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T262ECGU0002626.22e-03
9238Gamma glutamyl transpeptidaseGCST900187346.21e-03
9239Age spotsGCST0060966.20e-03
9240CCDC80 levelsGCST904685626.20e-03
9241aparc-Desikan lh volume lingualGCST900027806.18e-03
9242Volume of right anterior amygdaloid areaGCST904750006.17e-03
9243aparc-Desikan lh area cuneusGCST900030776.17e-03
9244FSHB levelsGCST904692706.17e-03
9245Hyperplasia of prostate (PheCode 600)GCST904761536.16e-03
9246ICD10 O42: Premature rupture of membranesGCST904542386.15e-03
9247aparc-a2009s lh volume S-calcarineGCST900029686.14e-03
9248DTI autoptx L2 unc r tractGCST903851926.14e-03
9249Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T36ECGA0000366.14e-03
9250Cystatin C levels in bottom 99% of individuals by creatinine levelsGCST905667346.13e-03
9251MED18/TBL1X ratioGCST903154156.13e-03
9252CASP2 levelsGCST904685446.12e-03
9253Ankle spacing width (left) | Bone-densitometry of heelUKBB000000336.11e-03
9254Gallbladder polypGCST900186266.09e-03
9255ANXA1 levelsGCST902402966.09e-03
9256Frequency of light DIY in last 4 weeks | Physical activityUKBB000002646.07e-03
9257Indolebutyrate levelsGCST901997596.07e-03
9258EGLN1/PSIP1 ratioGCST903146206.04e-03
9259Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T472ECGA0004726.03e-03
9260DTI TBSS L2 Anterior limb of internal capsule LGCST903844936.03e-03
9261Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T269ECGA0002696.03e-03
9262Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T457ECGA0004576.02e-03
9263aseg lh intensity Inf-Lat-VentGCST900037656.01e-03
9264Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T271ECGA0002716.01e-03
9265Obstructive sleep apnea (PheCode 327.32)GCST904758256.01e-03
9266Beetroot likingGCST900947025.99e-03
9267BSG/IL12A_IL12B ratioGCST903135325.99e-03
9268Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T263ECGA0002635.98e-03
9269IZUMO4 levelsGCST904237925.98e-03
9270Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T415ECGA0004155.97e-03
9271Dysmenorrheic pain severityGCST0066565.97e-03
9272Coffee intake | DietUKBB000001385.95e-03
9273Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T418ECGA0004185.94e-03
9274X-24328 levelsGCST902006245.93e-03
9275Autorefraction - 6mm strong meridian angle (right) | EyesightUKBB000000785.92e-03
9276Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T37ECGA0000375.90e-03
9277Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T458ECGA0004585.89e-03
9278Headaches for 3+ months | PainUKBB000003075.88e-03
9279MRPL33 levelsGCST906179865.87e-03
9280STROKEFING000013365.87e-03
9281Cerebrospinal fluid 3-hydroxy-2-ethylpropionate levelsGCST903179645.84e-03
9282Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)FING000007545.83e-03
9283Diaphragmatic hernia (PheCode 550.2)GCST904760615.82e-03
9284LAT2/YES1 ratioGCST903152825.82e-03
9285Statin-associated type 2 diabetes mellitusGCST906525175.82e-03
9286Breast cancer (PheCode 174)GCST904356005.76e-03
9287Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T159ECGU0001595.76e-03
9288CLMP/TNFRSF19 ratioGCST903141365.75e-03
9289TNFSF10 levelsGCST902748435.75e-03
9290Right-hemisphere visual network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903027765.74e-03
9291monocyte (fraction, mean, inv-norm transformed)GCST904755115.74e-03
9292PFKFB2/SRP14 ratioGCST903156505.73e-03
9293F-fatty/dairy food liking (derived food-liking factor)GCST900947605.72e-03
9294IL18RAP levelsGCST904695665.72e-03
9295Time spent outdoors in winter | Sun exposureUKBB000008195.70e-03
92961-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) levelsGCST902000705.68e-03
9297ObesityGCST0014755.68e-03
9298TGFBR2/TNFRSF19 ratioGCST903159175.67e-03
9299EDAR/TREML2 ratioGCST903145925.63e-03
9300T1 FreeSurfer DK lh precuneus volumeGCST903856805.61e-03
9301Psoriasis (vulgaris), strict definitionFING000012235.58e-03
9302T1 FreeSurfer a2009s rh S calcarine areaGCST903849335.58e-03
9303Eosinophil count varianceGCST905656895.58e-03
9304Adhesive capsulitis of shoulderFING000000435.57e-03
9305Wheeze or whistling in the chest in last year (UKB data field 2316)GCST900436145.57e-03
9306CD244/EDAR ratioGCST903137645.56e-03
9307Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T272ECGA0002725.56e-03
9308Nasal polypFING000008585.56e-03
9309DorsopathiesFING000004735.55e-03
9310Atopic/contact dermatitis due to other or unspecified (PheCode 939)GCST904762895.54e-03
9311Volume of left accessory basal nucleusGCST904749405.54e-03
9312Bread intake | DietUKBB000001055.51e-03
9313MYOC levelsGCST904228255.49e-03
9314Other peripheral nerve disorders (PheCode 351)GCST904758425.47e-03
9315Valine levelsGCST901327525.47e-03
9316Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T236ECGU0002365.44e-03
9317Other reaction to severe stress, and adjustment disordersFING000010925.44e-03
9318PAG1 levelsGCST904701475.43e-03
9319CTSH levelsGCST900885015.42e-03
9320SCAMP3/VPS53 ratioGCST903158075.41e-03
9321diastolic blood pressure (DBP, mean, inv-normal transformed)GCST904752555.41e-03
9322IDP T1 SIENAX grey normalised volumeGCST900024305.41e-03
9323Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T421ECGA0004215.41e-03
9324aparc-Desikan lh volume superiorparietalGCST900027965.39e-03
9325IDP dMRI TBSS MD Inferior cerebellar peduncle RGCST900040375.38e-03
9326Prolapse of vaginal walls | genitourinaryUKBB000007125.37e-03
9327Other (seronegative) rheumatoid arthritis, wideFING000009175.37e-03
9328Volume of right accessory basal nucleusGCST904750065.35e-03
9329EGLN1/PIK3AP1 ratioGCST903146195.34e-03
9330DPEP1 levelsGCST900903025.32e-03
9331DTI autoptx L1 cst l tractGCST903851475.31e-03
9332T1 FreeSurfer a2009s lh S temporal sup areaGCST903847405.30e-03
9333Phosphatidylethanolamine_40:6_[M-H]1- levelsGCST900603655.29e-03
9334T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 85)GCST903209045.28e-03
9335Alanine levelsGCST902435825.28e-03
9336IDP SWI T2star right pallidumGCST900038705.27e-03
9337Glycated hemoglobin levelsGCST900022435.27e-03
9338Autorefraction - 3mm weak meridian angle (left) | EyesightUKBB000000715.24e-03
9339Waist circumference adjusted for body mass indexGCST0122265.24e-03
9340Omega-6 fatty acid levelsGCST905025195.23e-03
9341aparc-a2009s rh area S-calcarineGCST900034145.20e-03
9342aparc-a2009s lh area S-precentral-sup-partGCST900033655.20e-03
9343CXCL5/PLXNA4 ratioGCST903143515.19e-03
9344Other/unspecified dorsalgiaFING000011245.19e-03
9345TWF2 levelsGCST904709875.18e-03
9346Handedness (chirality/laterality) - Left-handed | Early life factorsUKBB000003025.18e-03
9347wg rh intensity-contrast postcentralGCST900038485.18e-03
9348T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 114)GCST903206775.17e-03
9349FGR/LBR ratioGCST903148145.17e-03
9350Vertiginous syndromes and other disorders of vestibular system (PheCode 386)GCST904759055.17e-03
9351AsthmaGCST904760245.16e-03
9352Urine proline levels in chronic kidney diseaseGCST902658735.15e-03
9353Cerebrospinal fluid proline levelsGCST903182515.15e-03
9354TMSB10/TREML2 ratioGCST903159235.15e-03
9355SLC39A14 levelsGCST904706605.13e-03
9356DCTPP1 levelsGCST904689615.13e-03
9357Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T196ECGA0001965.12e-03
9358Knee osteoarthritisGCST0070905.12e-03
9359BA-exvivo lh area BA3bGCST900032105.12e-03
9360T1 FreeSurfer a2009s rh Pole occipital areaGCST903849315.12e-03
9361eGFR in diabetes mellitus (loose) case-control group (minimal adjustment)GCST906247905.10e-03
9362FBLN2 levelsGCST904691935.09e-03
9363CA1/CA2 ratioGCST903135715.03e-03
9364MESD/SNX9 ratioGCST903154235.02e-03
9365Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T405ECGA0004054.99e-03
9366Eosinophil countGCST900259874.97e-03
9367Calculus of kidney and ureterFING000002364.97e-03
9368DTI TBSS FA Posterior limb of internal capsule RGCST903843984.97e-03
9369Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T29ECGU0000294.97e-03
9370FABP9 levelsGCST904691794.94e-03
9371GGT1/MME ratioGCST903149304.93e-03
9372CD40 levelsGCST900120654.93e-03
9373CD209/CLEC14A ratioGCST903137494.93e-03
9374aparc-Desikan lh area supramarginalGCST900031034.93e-03
9375Other disorders of stomach and duodenum (PheCode 537)GCST904760544.93e-03
9376ANGPT1/CPXM1 ratioGCST903132624.91e-03
9377LGMN/TIMP1 ratioGCST903153254.90e-03
9378X-12749 levelsGCST902437704.90e-03
9379Endometriosis of ovaryFING000005014.88e-03
9380EndometriosisGCST900186194.87e-03
9381Status post-amiFING000013334.85e-03
9382ICD10 N81: Female genital prolapseGCST904542144.85e-03
9383Left ventricular mass (indexed to body surface area)GCST904352604.85e-03
9384ITGB1BP2/WASF1 ratioGCST903152244.84e-03
9385Hearing difficultyGCST900447754.84e-03
9386HSPA1A/MGLL ratioGCST903150834.83e-03
9387Dermatomycosis (PheCode 110.2)GCST904755654.83e-03
9388Endometriosis diagnosis and infertility diagnosis occurring togetherFING000004994.81e-03
9389Treatment or medication use - insulin product (UKB data field 20003_1140883066)GCST900422264.80e-03
9390NUCB2/TXNDC5 ratioGCST903155784.80e-03
9391aparc-a2009s lh volume G-cingul-Post-ventralGCST900029344.80e-03
9392aparc-a2009s lh area G-parietal-supGCST900033234.80e-03
9393Placental weight (paternal genotype, adjusted for sex and gestational age)GCST902751914.79e-03
9394NTN4 levelsGCST902420494.79e-03
9395aparc-Desikan rh area isthmuscingulateGCST900031164.78e-03
9396aparc-DKTatlas lh area supramarginalGCST900032634.78e-03
9397Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T263ECGU0002634.78e-03
9398Emotional neglectGCST905518464.77e-03
9399FCRL1/TCL1A ratioGCST903147954.76e-03
9400PHLDB1 levelsGCST904702254.76e-03
9401aparc-pial rh area cuneusGCST900031784.76e-03
9402aparc-Desikan lh volume supramarginalGCST900027984.76e-03
9403IDP T1 FAST ROIs V cerebellum VIIIaGCST900025794.76e-03
9404aparc-DKTatlas lh volume pericalcarineGCST900028814.76e-03
9405CD22/TCL1A ratioGCST903137604.75e-03
9406Acute alcohol intoxicationFING000000144.75e-03
9407LYZL2 levelsGCST904698334.73e-03
9408Hair colour (natural, before greying): Black (UKB data field 1747_5)GCST900418404.71e-03
9409DTI TBSS FA Sagittal stratum LGCST903844114.69e-03
9410Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T2ECGU0000024.69e-03
9411Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T76ECGU0000764.68e-03
9412T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 32)GCST903205954.68e-03
9413CFI levelsGCST902407824.67e-03
9414Mouth/teeth dental problems - Mouth ulcers | MouthUKBB000004884.67e-03
9415Other septicaemiaFING000010974.66e-03
9416Polymyalgia rheumaticaFING000011884.65e-03
9417MANF/SNX9 ratioGCST903153684.65e-03
9418Volume of left basal nucleusGCST904749464.64e-03
9419Sum eosinophil basophil countsGCST0046244.63e-03
9420Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T40ECGA0000404.63e-03
9421Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T274ECGU0002744.61e-03
9422FCRL3 levelsGCST904692074.60e-03
9423CD55/PTGDS ratioGCST903138474.60e-03
9424Eosinophil countGCST0046064.58e-03
9425Forced expiratory volume in 1 second FEV1 Z score (UKB data field 20256)GCST904681664.57e-03
9426aparc-pial rh area superiorparietalGCST900032024.55e-03
9427SIGLEC8 levelsGCST900898864.53e-03
9428Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T197ECGA0001974.53e-03
9429Acid reflux/GERDGCST904753204.52e-03
9430Pulse wave reflection index | Arterial stiffnessUKBB000007264.52e-03
9431CD19 on IgD- CD27- B cellGCST900017324.51e-03
9432Right-hemisphere control network to amygdala white-matter structural connectivityGCST903028414.49e-03
9433Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T468ECGA0004684.48e-03
9434Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T273ECGA0002734.48e-03
9435Percentage of fucosylation of monogalactosylated structures in total neutral plasma glycans (GP74)GCST906685184.46e-03
9436Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)GCST901322274.46e-03
9437BTN2A1/SMOC2 ratioGCST903135494.45e-03
9438Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T211ECGU0002114.42e-03
9439Eosinophil countGCST900023814.41e-03
9440ART3/RGMA ratioGCST903133624.41e-03
9441Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T82ECGU0000824.38e-03
9442MSMB levelsGCST904699494.37e-03
9443Number of incorrect matches in round | Pairs matchingUKBB000005384.36e-03
9444Light smokers, at least 100 smokes in lifetime | SmokingUKBB000004074.36e-03
9445IDP T1 FAST ROIs R temporal poleGCST900024664.36e-03
9446wg lh intensity-contrast postcentralGCST900038134.34e-03
9447T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41)GCST903208604.34e-03
9448CCER2 levelsGCST904685634.34e-03
9449Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T274ECGA0002744.33e-03
9450Female genital prolapse | Noninflammatory disorders of female genital tractUKBB000002444.33e-03
9451Basophil countGCST900023794.33e-03
9452Mean platelet volumeGCST900023954.32e-03
9453aparc-a2009s rh area G-oc-temp-med-LingualGCST900033924.32e-03
9454CEP43/USP8 ratioGCST903140224.31e-03
9455IDP dMRI TBSS L3 Retrolenticular part of internal capsule LGCST900041924.31e-03
9456ICD10 C61: Malignant neoplasm of prostateGCST900438944.31e-03
9457T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 43)GCST903206064.30e-03
9458Other retinal disordersFING000010944.29e-03
9459Urine X-23518 levels in chronic kidney diseaseGCST902665954.28e-03
9460AMBP levelsGCST904682884.27e-03
9461Pain and other conditions associated with female genital organs and menstrual cycleFING000011364.24e-03
9462DNAJB14 levelsGCST904272354.24e-03
9463aseg lh intensity VentralDCGCST900037754.23e-03
9464Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T465ECGA0004654.23e-03
9465Rheumatoid arthritisGCST0006794.22e-03
9466Biological Father: Cancer, SkinGCST904752404.22e-03
9467Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T213ECGU0002134.22e-03
9468T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68)GCST903208874.22e-03
9469Operative procedures - Endoscopic resection of semilunar cartilage NEC | Summary OperationsUKBB000005774.22e-03
9470ATP5IF1/LYN ratioGCST903133894.20e-03
9471wg rh intensity-contrast entorhinalGCST900038324.19e-03
9472Principal component-derived dietary pattern 4GCST901330094.19e-03
9473HippSubfield rh volume CA1-bodyGCST900026924.19e-03
9474Granulocyte percentage of myeloid white cellsGCST0046084.18e-03
9475Degeneration of intervertebral disc (PheCode 722.6)GCST904762384.18e-03
9476CCL3 levelsGCST900120554.17e-03
9477Takes medication for circulatory problem?GCST904752184.15e-03
9478Operative procedures - Carpal tunnel release | Summary OperationsUKBB000005744.15e-03
9479Right-hemisphere default mode network to amygdala white-matter structural connectivityGCST903028494.15e-03
9480aparc-a2009s rh volume G-pariet-inf-SupramarGCST900030244.14e-03
9481Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T470ECGA0004704.14e-03
9482CA5A levelsGCST904685144.14e-03
9483EpiscleritisFING000005134.14e-03
9484T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 119)GCST903206824.14e-03
9485OTUD7B levelsGCST904701374.13e-03
9486DTI TBSS L3 Fornix cres+Stria terminalis LGCST903845634.13e-03
9487Other peripheral vertigoFING000010884.10e-03
9488DDHD2 levelsGCST904689684.10e-03
9489IDP dMRI TBSS FA Splenium of corpus callosumGCST900038814.09e-03
9490Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T28ECGU0000284.09e-03
9491HAVCR1 levelsGCST904694314.08e-03
9492ENO2/RWDD1 ratioGCST903146674.08e-03
9493Progressive vascular leukoencephalopathyFING000012184.06e-03
9494CD40/IGSF8 ratioGCST903138154.06e-03
9495SMOC2 levelsGCST904706834.05e-03
9496CEACAM8/MMP9 ratioGCST903140024.04e-03
9497FHIT/MAX ratioGCST903148184.03e-03
9498Glycine levelsGCST902435814.03e-03
9499Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T4ECGU0000044.03e-03
9500Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T268ECGA0002684.03e-03
9501FEV1GCST0074324.02e-03
9502T1 FreeSurfer aseg Right-PallidumGCST903841644.02e-03
9503Left ventricular stroke volumeGCST902681304.01e-03
9504T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 73)GCST903206364.01e-03
9505aparc-pial rh area parstriangularisGCST900031934.01e-03
9506KIFBP/TACC3 ratioGCST903152494.01e-03
9507MMP1 levelsGCST904699194.01e-03
9508Eosinophil countGCST900187334.00e-03
9509Disorders of synovium and tendonFING000004624.00e-03
9510Rheumatoid arthritisFING000012674.00e-03
9511WNT9A levelsGCST904710794.00e-03
9512Sleep apneaGCST904758243.99e-03
9513Open wounds of extremities (PheCode 871)GCST904762853.99e-03
9514KLK10 levelsGCST904696963.98e-03
9515ARHGEF1 levelsGCST904683593.97e-03
9516Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T161ECGU0001613.96e-03
9517Synonym | Fluid intelligence / reasoningUKBB000008023.95e-03
9518Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T9ECGU0000093.95e-03
9519CLEC4D/MANSC1 ratioGCST903141123.93e-03
9520All anxiety disordersFING000000593.93e-03
9521wg rh intensity-contrast lateraloccipitalGCST900038373.91e-03
9522Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T212ECGU0002123.91e-03
9523Mean platelet thrombocyte volume (UKB data field 30100)GCST904680873.91e-03
9524BAIAP2/MME ratioGCST903134533.90e-03
9525Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T409ECGA0004093.90e-03
9526S100G levelsGCST904705193.90e-03
9527EDAR/TACC3 ratioGCST903145893.89e-03
9528SORCS2 levelsGCST904707083.87e-03
9529CALB2 levelsGCST904685273.87e-03
9530Emotionally unstable personality disorderFING000004953.86e-03
9531Recent feelings of depression | DepressionUKBB000007373.86e-03
9532Current employment status - Retired | EmploymentUKBB000001593.86e-03
9533Other ulcerative colitisFING000011173.86e-03
9534GPI levelsGCST902412693.85e-03
9535Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T5ECGU0000053.84e-03
9536ACAA1 levelsGCST904681933.83e-03
9537BCL2L2 levelsGCST904220773.83e-03
9538Left-hemisphere visual network to pallidum white-matter structural connectivityGCST903026653.83e-03
9539Hernia of abdominal wall, postoperativeFING000006183.83e-03
9540IDP dMRI TBSS OD External capsule RGCST900044343.81e-03
9541HippSubfield rh volume CA3-bodyGCST900027023.80e-03
9542CD84/VASH1 ratioGCST903139203.80e-03
9543Other neurological diseasesFING000010743.79e-03
9544Clonal hematopoiesis (overall)GCST904353533.78e-03
9545IDP dMRI TBSS L2 Anterior corona radiata RGCST900041453.78e-03
9546KLK15 levelsGCST904697013.78e-03
9547Seronegative rheumatoid arthritisFING000012963.77e-03
9548ERBIN/LYN ratioGCST903146943.76e-03
9549FGF23 levelsGCST900120223.75e-03
9550Trigger fingerGCST901049073.75e-03
9551MAVS/TBL1X ratioGCST903153993.74e-03
9552GZMA/GZMH ratioGCST903150083.73e-03
9553Volume of right cortical nucleusGCST904750333.71e-03
9554MPI/TACC3 ratioGCST903154913.70e-03
9555REST UKBBICA NET100 1212GCST903870663.67e-03
9556GDI2 levelsGCST900880043.66e-03
9557Hand grip strength (left) | Hand grip strengthUKBB000003003.65e-03
9558Excessive scarringGCST904833683.65e-03
9559Other disorders of fluid, electrolyte and acid-base balanceFING000010273.65e-03
9560Overweight, obesity and other hyperalimentation | endocrine/metabolicUKBB000006223.64e-03
9561T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 97)GCST903209163.63e-03
9562Sequelae of cerebrovascular diseaseFING000012943.63e-03
9563Ectopic pregnancyGCST902728833.62e-03
9564Hair colour (natural, before greying): Red (UKB data field 1747_2)GCST900418373.61e-03
9565ICD10 O00: Ectopic pregnancyGCST904542273.61e-03
9566Lysoalkylphosphatidylcholine (O-24:0) levelsGCST900254363.60e-03
9567Cis-4-decenoylcarnitine (C10:1) metabolite levelGCST906157293.59e-03
9568Takes medication for acid reflux/GERD?GCST904753213.59e-03
9569Butternut squash likingGCST900947183.59e-03
9570Illnesses of siblings - High blood pressure | Family historyUKBB000003523.59e-03
9571Pain in thoracic spineFING000011393.59e-03
9572Attention deficit hyperactivity disorderGCST0053623.57e-03
9573IDP dMRI TBSS L2 Tapetum LGCST900041703.56e-03
9574Risk taking | Mental healthUKBB000007593.55e-03
9575Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T439ECGU0004393.55e-03
9576Maternal care for other conditions predominantly related to pregnancyFING000007913.54e-03
9577T1 FreeSurfer DK rh MeanThickness thicknessGCST903857573.54e-03
9578MAX/STK24 ratioGCST903154043.54e-03
9579TNFSF14 levelsGCST902748423.53e-03
9580Lysine levelsGCST902004023.53e-03
9581MESD/VASH1 ratioGCST903154253.52e-03
9582Insomnia complaintsGCST0046953.51e-03
9583Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T195ECGA0001953.50e-03
9584Primary open-angle glaucoma, strictFING000012143.50e-03
9585T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86)GCST903206493.49e-03
9586aparc-a2009s rh area S-collat-transv-antGCST900034203.48e-03
9587Non-cancer illness code, self-reported - diabetes | Medical conditionsUKBB000005083.47e-03
9588Cabbage likingGCST900947193.47e-03
9589DXO levelsGCST904690553.47e-03
9590ITGB1BP2/USP8 ratioGCST903152233.47e-03
9591CX3CL1/RGMB ratioGCST903143273.46e-03
9592Frailty (Factor 3 - Multimorbidity)GCST906240493.46e-03
9593Autorefraction - 3mm strong meridian (left) | EyesightUKBB000000653.45e-03
9594IDP dMRI ProbtrackX L3 ar rGCST900043013.45e-03
9595T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57)GCST903208763.44e-03
9596aparc-DKTatlas lh area superiorparietalGCST900032613.44e-03
9597Glomerular filtration rate (creatinine)GCST0033723.43e-03
9598SDHB levelsGCST904705613.42e-03
9599Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T140ECGU0001403.42e-03
9600OPHN1 levelsGCST904701263.42e-03
9601Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T123ECGA0001233.40e-03
9602Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T416ECGA0004163.39e-03
9603CD300E levelsGCST904686213.39e-03
9604Cancer of bladder (PheCode 189.2)GCST904755983.39e-03
9605Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T198ECGA0001983.39e-03
9606FUT8/RSPO1 ratioGCST903148913.38e-03
9607SEMA4D/TREML2 ratioGCST903158233.38e-03
9608Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T12ECGU0000123.36e-03
9609Humerus length to body height ratioGCST902702593.35e-03
9610Major depressive disorderGCST0099793.35e-03
9611GBP2 levelsGCST904693123.33e-03
96125-oxoproline levelsGCST902434373.33e-03
9613CCN2 levelsGCST904685883.32e-03
9614Medication use (antiglaucoma preparations and miotics)GCST900187823.31e-03
9615Fasting glucoseGCST900022313.31e-03
9616CD5L levelsGCST904686403.31e-03
9617Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T158ECGU0001583.30e-03
9618Birth weightGCST0075573.29e-03
9619Other arrhythmiasFING000009623.28e-03
9620IDP dMRI TBSS FA Tapetum LGCST900039243.28e-03
9621Autoimmune hyperthyroidismFING000001343.28e-03
9622Enthesopathies of lower limb, excluding footFING000005093.27e-03
9623MRC1 levelsGCST904699393.26e-03
9624Able to confide | Social supportUKBB000000043.26e-03
9625Glomerular filtration rate in non diabetics (creatinine)GCST0034013.25e-03
9626GCC1 levelsGCST904693153.24e-03
9627Basophil countGCST900259973.24e-03
9628KAZN levelsGCST904696663.24e-03
9629IDP dMRI TBSS MO Medial lemniscus LGCST900039613.24e-03
9630Atrial fibrillationGCST906244123.24e-03
9631AMBP/HAVCR1 ratioGCST903132543.23e-03
9632AmygNuclei rh volume Cortical-nucleusGCST900026643.22e-03
9633ART3 levelsGCST904683703.22e-03
9634CCN2/DKK1 ratioGCST903137103.21e-03
9635aparc-Desikan lh area superiorparietalGCST900031013.21e-03
9636Brain age gapGCST905580343.21e-03
9637T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 74)GCST903206373.21e-03
9638Lung function (FEV1/FVC)GCST0074313.20e-03
9639Androstenediol (3beta,17beta) monosulfate (2) levelsGCST901998713.20e-03
9640Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T1ECGU0000013.19e-03
9641Atrial fibrillation (MTAG)GCST904490543.19e-03
9642Malignant neoplasm of bladder (PheCode 189.21)GCST904755993.18e-03
9643wg lh intensity-contrast superiortemporalGCST900038213.18e-03
9644Cardiac dysrhythmias | circulatory systemUKBB000001193.17e-03
9645Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T261ECGA0002613.17e-03
9646Optic disc areaGCST0040763.16e-03
9647IDP dMRI TBSS L1 Retrolenticular part of internal capsule LGCST900040963.16e-03
9648aparc-DKTatlas lh volume lingualGCST900028733.16e-03
9649Retinal venular widthGCST902704003.15e-03
9650Caries in Clefts patientsFING000002563.15e-03
9651CNST/PRKAR1A ratioGCST903141613.14e-03
9652CD22/FCRL1 ratioGCST903137573.14e-03
9653SNX9/VASH1 ratioGCST903158663.13e-03
9654T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 44)GCST903206073.13e-03
9655Retention of urine (PheCode 599.2)GCST904761503.13e-03
9656PRTN3/RETN ratioGCST903157343.13e-03
9657Right-hemisphere somatomotor network to pallidum white-matter structural connectivityGCST903027973.13e-03
9658Duration screen displayed | Prospective memoryUKBB000002013.12e-03
9659T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 83)GCST903209023.11e-03
96601-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) levelsGCST902000833.11e-03
9661Volume of right medial nucleusGCST904749253.10e-03
96622-hydroxyisobutyrate levelsGCST902435393.09e-03
9663Seropositive rheumatoid arthritis, strict definitionFING000012973.09e-03
9664Transport type for commuting to job workplace - Public transport | EmploymentUKBB000008283.08e-03
9665Percentage of monosialylation of core-fucosylated monogalactosylated structures without bisecting GlcNAc (GP41)GCST906684853.08e-03
9666CTBS levelsGCST904689003.07e-03
9667AV-blockFING000001373.07e-03
9668Ankle spacing width (right) | Bone-densitometry of heelUKBB000000343.07e-03
9669Cerebrospinal fluid 5-methylthioadenosine (MTA) levelsGCST903182163.07e-03
9670BTN2A1 levelsGCST904684803.06e-03
9671CEP85 levelsGCST904687163.05e-03
9672IDP dMRI ProbtrackX MD atr lGCST900042213.04e-03
9673CD300C/HAVCR2 ratioGCST903137893.04e-03
9674Creatinine levelsGCST904972363.03e-03
9675Hand grip strength left (UKB data field 46)GCST904681683.02e-03
9676IDP dMRI TBSS L3 Posterior limb of internal capsule RGCST900041893.02e-03
9677Non-cancer illness code, self-reported - gastro-oesophageal reflux (gord) / gastric reflux | Medical conditionsUKBB000005103.02e-03
9678UBAC1 levelsGCST904709993.01e-03
9679CD40/TNFRSF14 ratioGCST903138303.00e-03
9680IDUA levelsGCST904695083.00e-03
9681F-small fish liking (derived food-liking factor)GCST900948403.00e-03
9682Volume of left paralaminar nucleusGCST904749822.99e-03
9683Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T273ECGU0002732.99e-03
9684ENO2/TACC3 ratioGCST903146702.98e-03
9685Time spend outdoors in summer | Sun exposureUKBB000008172.98e-03
9686CDC42BPB levelsGCST904686662.98e-03
9687SIGLEC6 levelsGCST904706342.98e-03
9688N6-acetyllysine levels in chronic kidney diseaseGCST902575312.97e-03
9689GZMA/LTA ratioGCST903150122.95e-03
9690Lung function (FEV1/FVC)GCST900259782.95e-03
9691Ventricular arrhythmiaGCST900187202.95e-03
9692IDP dMRI TBSS FA External capsule RGCST900039092.94e-03
9693monocyte (absolute count, mean, inv-norm transformed)GCST904755022.93e-03
9694Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T463ECGA0004632.92e-03
9695aparc-a2009s lh area S-postcentralGCST900033632.92e-03
9696Waist circumference adjusted for body mass indexGCST903028922.91e-03
9697Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T484ECGA0004842.91e-03
9698IDP T1 FAST ROIs R front operc cortexGCST900025322.91e-03
9699KLK14 levelsGCST904274282.90e-03
9700RUNX3 levelsGCST902427062.90e-03
9701Other hypertrophic and atrophic conditions (PheCode 701)GCST904761972.90e-03
9702aparc-DKTatlas rh volume pericalcarineGCST900029122.88e-03
9703Oral glucose tolerance test-2hGCST902977902.87e-03
9704Early lumbar disc prolapse, operatedFING000004842.87e-03
9705Morning/evening person (chronotype) | SleepUKBB000004832.87e-03
9706Calcium levelsGCST900187312.87e-03
9707ERP29 levelsGCST904691492.86e-03
9708ANP32B levelsGCST902401762.84e-03
9709BCAN/KLK6 ratioGCST903134792.84e-03
9710HMBS/UBAC1 ratioGCST903150662.83e-03
9711Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T27ECGU0000272.83e-03
9712T1 FreeSurfer aseg Left-PallidumGCST903841462.83e-03
9713Plays computer games | Electronic device useUKBB000006492.83e-03
9714Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T145ECGU0001452.82e-03
9715Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T64ECGU0000642.82e-03
9716Cardiovascular delta age (difference between ECG-predicted and chronological age)GCST902397492.81e-03
9717T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125)GCST903206882.81e-03
9718IDP dMRI ProbtrackX L1 cgc rGCST900042512.80e-03
9719BANK1 levelsGCST904684212.80e-03
9720GRPEL1/MME ratioGCST903149922.80e-03
9721CC2D1A/TMSB10 ratioGCST903136672.80e-03
9722Fluid intelligence score (baseline)GCST905658422.79e-03
9723Eosinophil countGCST900022992.79e-03
9724Breathing problems during period of job | Employment historyUKBB000001112.79e-03
9725aparc-DKTatlas lh area cuneusGCST900032372.79e-03
9726wg lh intensity-contrast pericalcarineGCST900038122.78e-03
9727Corns and callosities (PheCode 700)GCST904761962.78e-03
9728Breast cancer [female] | neoplasmsUKBB000001082.77e-03
9729Volume of right anterior amygdaloid areaGCST904749042.77e-03
9730aparc-a2009s lh area G-pariet-inf-SupramarGCST900033222.77e-03
9731FEV1 FVC ratio Z score (UKB data field 20258)GCST904681652.77e-03
9732BA-exvivo rh volume V1GCST900028582.77e-03
9733Occlusion and stenosis of precerebral arteries (PheCode 433.1)GCST904759862.77e-03
9734Intervertebral disc disorders (PheCode 722)GCST904762372.76e-03
9735Wheeze or whistling in the chest in last year | BreathingUKBB000009122.75e-03
9736Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T417ECGA0004172.75e-03
9737Operative procedures - Primary total prosthetic replacement of knee joint using cement | Summary OperationsUKBB000005882.75e-03
9738Bread type - Wholemeal or wholegrain | DietUKBB000001072.74e-03
9739chloride (mean, inv-norm transformed)GCST904751942.74e-03
9740Macular degenerationGCST904753862.74e-03
9741Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T149ECGU0001492.74e-03
9742Weight (maximum, inv-normal transformed)GCST904764602.73e-03
9743Fracture of lower limb | injuries & poisoningsUKBB000002552.73e-03
9744Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T44ECGA0000442.72e-03
9745ABHD14B/SCRN1 ratioGCST903131452.71e-03
9746BA-exvivo rh volume BA3bGCST900028522.71e-03
9747CD70 levelsGCST904686452.70e-03
9748Hereditary deficiency of other clotting factorsFING000006122.69e-03
9749BAIAP2 levelsGCST904684192.69e-03
9750CALCOCO1/CASP8 ratioGCST903135972.68e-03
9751EDAR/YES1 ratioGCST903145942.68e-03
9752aparc-a2009s rh thickness G+S-cingul-AntGCST900036822.68e-03
9753F-savoury food liking (derived food-liking factor)GCST900948332.68e-03
9754Thyrotoxicosis with toxic multinodular goitreFING000013622.67e-03
9755Prostate cancerGCST900118082.67e-03
9756Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T474ECGA0004742.67e-03
9757Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T53ECGU0000532.66e-03
9758Histidine levelsGCST904974792.65e-03
9759Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T481ECGA0004812.65e-03
9760Other disorders of skin and subcutaneous tissue, not elsewhere classifiedFING000010362.65e-03
9761Systemic lupus erythematosusGCST900142382.64e-03
9762IRAG2 levelsGCST904696262.63e-03
9763Diastolic blood pressureGCST900187322.63e-03
9764Asthma-related acute respiratory infectionsFING000001172.61e-03
9765MPHOSPH8/USP8 ratioGCST903154792.61e-03
9766Types of transport used (excluding work) - Public transport | Physical activityUKBB000008782.61e-03
9767IDP dMRI ProbtrackX L3 ilf lGCST900043142.60e-03
9768Pain type(s) experienced in last month - Hip pain | PainUKBB000006282.59e-03
9769Oral glucose tolerance test-1hGCST902977892.59e-03
9770ANGPT1/EGF ratioGCST903132642.59e-03
9771Bread consumption (slices per week) (UKB data field 1438)GCST901329812.59e-03
9772HLA-DMA levelsGCST902414482.58e-03
9773T1 FreeSurfer BA rh V2 exvivo thicknessGCST903855712.58e-03
9774Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T214ECGU0002142.58e-03
9775LGALS4 levelsGCST904697622.57e-03
9776IDP T1 FAST ROIs L cerebellum IXGCST900025842.57e-03
9777AsthmaGCST900860472.57e-03
9778wg rh intensity-contrast precentralGCST900038502.57e-03
9779Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T220ECGA0002202.56e-03
9780AnginaGCST904681092.55e-03
9781Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025712.55e-03
9782Acquired toe deformities (PheCode 735.2)GCST904762492.55e-03
9783Frequency of drinking alcohol | Alcohol useUKBB000002602.54e-03
9784Mackerel likingGCST900947962.53e-03
9785Contracture of palmar fascia [Dupuytren's disease] (PheCode 728.71)GCST904762452.52e-03
9786Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T144ECGU0001442.52e-03
9787LAYN/VWC2 ratioGCST903152932.49e-03
9788Number of self-reported non-cancer illnesses | Medical conditionsUKBB000005412.49e-03
9789ARNT levelsGCST904683672.48e-03
97905alpha-pregnan-3beta,20alpha-diol monosulfate (2) levelsGCST901998542.47e-03
9791Graves disease, strict definitionFING000005922.47e-03
9792CALCOCO1 levelsGCST904685302.47e-03
9793PRKAB1 levelsGCST904703242.47e-03
9794Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T275ECGA0002752.46e-03
9795Poultry consumptionGCST901329962.45e-03
9796Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T51ECGA0000512.45e-03
9797IDP dMRI TBSS OD Tapetum RGCST900044482.44e-03
9798Octadecenedioylcarnitine (C18:1-DC) levelsGCST901999702.44e-03
9799PVALB levelsGCST904703932.44e-03
9800Stroke, excluding SAHFING000013372.44e-03
9801T1 CAT volume L LateralOccipitalCortexinferiordivisionGCST903840442.43e-03
9802End-diastolic bi-ventricular shape (principal component 8)GCST904484872.43e-03
9803aparc-a2009s rh volume S-oc-temp-med+LingualGCST900030592.42e-03
9804DAPK2 levelsGCST902408772.42e-03
9805BronchitisFING000002282.41e-03
9806DTI TBSS L2 External capsule RGCST903845082.40e-03
9807Glycated hemoglobin levelsGCST905664242.40e-03
9808DTI TBSS L3 Superior fronto-occipital fasciculus RGCST903845662.39e-03
9809PAEP/RSPO1 ratioGCST903155932.39e-03
9810Attention deficit hyperactivity disorderGCST905684412.39e-03
9811Urine glycocholenate sulfate* levels in chronic kidney diseaseGCST902652922.38e-03
9812Alcohol-related disorders | mental disordersUKBB000000262.38e-03
9813Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T54ECGU0000542.37e-03
9814IDP dMRI TBSS FA Posterior thalamic radiation LGCST900039062.37e-03
9815Malignant neoplasm of female breast | neoplasmsUKBB000004262.37e-03
9816rfMRI connectivity (ICA100 edge 951)GCST900058042.36e-03
9817T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 7)GCST903205702.36e-03
9818Time to complete round | Pairs matchingUKBB000008222.36e-03
9819IDP T1 FAST ROIs L cerebellum VIIIaGCST900025782.36e-03
9820IL2RB levelsGCST904695862.35e-03
9821Enteritis due to Yersinia enterocoliticaFING000005052.35e-03
9822T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 128)GCST903206912.34e-03
9823PTH1R levelsGCST904703712.34e-03
9824Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T154ECGU0001542.34e-03
9825Sleep apneaGCST904752572.34e-03
9826DTI autoptx L2 atr l tractGCST903851682.32e-03
9827PDCD1/TNFRSF9 ratioGCST903156112.32e-03
9828wg rh intensity-contrast transversetemporalGCST900038602.32e-03
9829aparc-Desikan lh volume pericalcarineGCST900027882.31e-03
9830ENO2/MGLL ratioGCST903146632.30e-03
9831PSMD9/UBAC1 ratioGCST903157352.30e-03
9832Osteoarthrosis, localized, primary (PheCode 740.11)GCST904762552.29e-03
9833CDKN2D/FOXO1 ratioGCST903139852.29e-03
9834IDP dMRI TBSS FA Tapetum RGCST900039232.29e-03
9835wg lh intensity-contrast rostralmiddlefrontalGCST900038182.27e-03
9836Alcohol drinker status - Never | AlcoholUKBB000000222.27e-03
9837FUT3 or FUT5 levelsGCST904692802.26e-03
9838aparc-DKTatlas rh area lingualGCST900032762.25e-03
9839CSNK2A1 or CSNK2B levelsGCST900889632.24e-03
9840DTI autoptx L3 str r tractGCST903852172.24e-03
9841ANXA4/CA13 ratioGCST903132902.24e-03
9842Blood cell traits latent factor 8 (white cell)GCST905592502.23e-03
9843QDPR/THOP1 ratioGCST903157572.23e-03
9844Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T272ECGU0002722.23e-03
9845IDP dMRI ProbtrackX L3 slf lGCST900043212.23e-03
9846Pelvic organ prolapseGCST901024702.23e-03
9847wg lh intensity-contrast precuneusGCST900038162.23e-03
9848T1 CAT volume R RightPutamenGCST903841012.22e-03
9849CD300E/CXCL10 ratioGCST903137962.22e-03
9850Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T217ECGU0002172.20e-03
9851GSTA1 levelsGCST904694112.20e-03
9852IGFBP6 levelsGCST904695312.20e-03
9853Right-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivityGCST903028162.20e-03
9854T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 75)GCST903208942.20e-03
9855BAG3 levelsGCST904684162.19e-03
9856SVEP1 levelsGCST902429282.18e-03
9857Histidine levels (UKB data field 23463)GCST902695602.18e-03
9858CA3 levelsGCST904685122.17e-03
9859rfMRI connectivity (ICA100 edge 383)GCST900052362.17e-03
9860Lumbar disc prolapseFING000007352.17e-03
9861Phenylalanine levelsGCST904992282.16e-03
9862wg lh intensity-contrast precentralGCST900038152.16e-03
9863Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T8ECGU0000082.16e-03
9864Biological Mother: Coronary Artery / Coronary Heart DiseaseGCST904754882.16e-03
9865IDP T1 FIRST left hippocampus volumeGCST900024442.16e-03
9866Basophil countGCST900022922.15e-03
9867T1 FreeSurfer BA lh V1 exvivo areaGCST903855142.15e-03
9868Cervicobrachial syndromeFING000002662.15e-03
9869Other and unspecified anaemiasFING000009252.15e-03
9870Left bundle-branch blockFING000007162.15e-03
9871F-acquired taste liking (derived food-liking factor)GCST900947912.15e-03
9872CDKN2D/TACC3 ratioGCST903139922.14e-03
9873ANXA10 levelsGCST904683142.14e-03
9874Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T146ECGU0001462.13e-03
9875wg lh intensity-contrast inferiorparietalGCST900037992.13e-03
9876Biological Sibling: Cancer, SkinGCST904763692.13e-03
9877Benign neoplasm: Sigmoid colonFING000002032.13e-03
9878Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T431ECGU0004312.13e-03
9879Postinfectious hypothyroidismFING000011922.13e-03
9880F-sauces liking (derived food-liking factor)GCST900948312.12e-03
9881TYRP1 levelsGCST904709982.12e-03
9882STX8 levelsGCST904707762.12e-03
9883rfMRI connectivity (ICA100 edge 1066)GCST900059192.12e-03
9884MB levelsGCST900120472.11e-03
9885T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 102)GCST903206652.11e-03
9886Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T423ECGA0004232.10e-03
9887Prescriptions - bendroflumethiazide | thiazide diuretic,diureticUKBB000006672.10e-03
9888Shellfish likingGCST900948382.10e-03
9889Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T453ECGA0004532.10e-03
9890aparc-Desikan rh volume pericalcarineGCST900028212.10e-03
9891TACC3/TRIAP1 ratioGCST903159012.10e-03
9892Job SOC coding: Heavy goods vehicle drivers (UKB data field 22617_8211)GCST900435522.10e-03
9893DSG2 levelsGCST904237662.08e-03
9894Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T434ECGU0004342.08e-03
9895Eosinophill count | Blood countUKBB000002062.08e-03
9896Diseases of esophagus | digestiveUKBB000001842.08e-03
9897Clonal haematopoiesis of indeterminate potential (DNMT3A mutation)GCST901652712.07e-03
9898MMP9 levelsGCST904699232.07e-03
9899MGLL/STK4 ratioGCST903154432.07e-03
9900PPL levelsGCST904702942.06e-03
9901Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T219ECGA0002192.06e-03
9902TAFA5 levelsGCST904708002.05e-03
9903Graves' diseaseGCST900186272.05e-03
9904EIF4G1 levelsGCST904690972.04e-03
9905Time spent using computer | Physical activityUKBB000008202.04e-03
9906Insulin fold change during an oral glucose tolerance testGCST902675682.04e-03
9907Atrial fibrillationGCST0064142.04e-03
9908BTN3A2 levelsGCST904684812.03e-03
9909ThyrotoxicosisFING000013602.03e-03
9910wg rh intensity-contrast pericalcarineGCST900038472.02e-03
9911HPSE levelsGCST904694732.02e-03
9912Pollock likingGCST900948132.02e-03
9913Fracture of radius and ulna (PheCode 803.2)GCST904762802.01e-03
9914NELL1 levelsGCST904700262.01e-03
9915CDH5/LGALS4 ratioGCST903139562.01e-03
9916T1 CAT volume R RightAccumbensGCST903841092.01e-03
9917Solitary pulmonary nodule (PheCode 514.2)GCST904760442.00e-03
9918BA-exvivo rh area V2GCST900032312.00e-03
9919Chronic obstructive pulmonary disease in ever smokersGCST900165882.00e-03
9920SELPLG levelsGCST900120462.00e-03
9921LAIR1 levelsGCST904697282.00e-03
9922PRRT3 levelsGCST904703402.00e-03
9923VASP levelsGCST904710281.99e-03
9924DNAJC21 levelsGCST904690161.98e-03
9925PMVK/RHOC ratioGCST903156971.98e-03
9926Comparative body size at age 10 | Early life factorsUKBB000001421.98e-03
9927EFHD1 levelsGCST904690791.98e-03
9928Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T267ECGU0002671.97e-03
9929Volume of left anterior amygdaloid areaGCST904749341.97e-03
9930DTI TBSS MD Fornix cres+Stria terminalis LGCST903846111.97e-03
9931Other menopausal disordersFING000010711.95e-03
9932ConstipationFING000003481.95e-03
9933Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T143ECGU0001431.95e-03
9934MMP10 levelsGCST900120501.95e-03
9935FEV1/FVC ratio | Other measurementUKBB000002451.95e-03
9936EDAR/EGF ratioGCST903145731.94e-03
9937Acute laryngitis and tracheitisFING000000231.94e-03
9938AKT1S1/MAX ratioGCST903132301.94e-03
9939CXCL16 levelsGCST902405241.94e-03
9940BA-exvivo rh volume BA2GCST900028501.94e-03
9941Other mental disorders due to brain damage and dysfunction and to physical diseaseFING000010721.93e-03
9942IL5RA levelsGCST904696001.93e-03
9943Systemic lupus erythematosusGCST900118661.92e-03
9944MAMDC4 levelsGCST904698421.92e-03
9945Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T456ECGA0004561.92e-03
9946Lysoalkylphosphatidylcholine (O-24:0) levelsGCST900248121.92e-03
9947Morbid obesity (PheCode 278.11)GCST904757651.91e-03
9948ROBO2/SFTPD ratioGCST903157851.91e-03
9949Fractured/broken bones in last 5 years | Medical conditionsUKBB000002581.91e-03
9950Atrial fibrillation and flutter (PheCode 427.2)GCST900439771.90e-03
9951SPINT1 levelsGCST904707271.90e-03
9952Visual disturbancesFING000014371.90e-03
9953Lignoceroylcarnitine (C24) levelsGCST902001371.90e-03
9954Left ventricular end diastole inferolateral wall thicknessGCST902785161.89e-03
9955ICD10 O13: Gestational hypertensionGCST904542321.89e-03
9956COVID-19 vaccinationGCST902556131.89e-03
9957Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T473ECGA0004731.88e-03
9958CSNK1G2 levelsGCST902406081.88e-03
9959Conduction disordersFING000003241.87e-03
9960BA-exvivo rh volume BA6GCST900028551.87e-03
9961CCL13/CCL17 ratioGCST903136741.87e-03
9962Tobacco useFING000013651.86e-03
9963Croissant likingGCST900947481.86e-03
9964MANF/SDC4 ratioGCST903153671.86e-03
9965Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T218ECGU0002181.86e-03
9966Thyroid problemsGCST904752761.86e-03
9967Depression | Mental distressUKBB000001651.85e-03
9968Bipolar disorderGCST0037241.84e-03
9969Placental weight (paternal genotype, adjusted for sex)GCST902751991.83e-03
9970CEP170 levelsGCST904687111.83e-03
9971T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 92)GCST903209111.82e-03
9972T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 93)GCST903209121.82e-03
9973PDGFB/TIMP3 ratioGCST903156311.80e-03
9974DNAJB14 levelsGCST902409521.80e-03
9975Ischemic strokeGCST0069081.80e-03
9976IDP dMRI ProbtrackX FA ar lGCST900039251.80e-03
9977TNFRSF8 levelsGCST904709151.79e-03
9978T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 102)GCST903209211.79e-03
9979GGT1 levelsGCST904693361.79e-03
9980T1 CAT volume L LeftAccumbensGCST903841081.79e-03
9981AGER levelsGCST900120541.78e-03
9982CEP43/MPHOSPH8 ratioGCST903140191.78e-03
9983Diastolic blood pressureGCST900259811.78e-03
9984Personal history of medical treatment | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000006431.77e-03
9985CSTB levelsGCST904688981.77e-03
9986Umbilical hernia (PheCode 550.4)GCST904760621.77e-03
9987RILP/RWDD1 ratioGCST903157781.77e-03
9988Muscular dystrophyFING000008481.77e-03
9989aparc-pial lh area superiorparietalGCST900031691.76e-03
9990EGF/TNFSF14 ratioGCST903146151.76e-03
9991Benign neoplasm of major salivary glandsFING000001571.75e-03
9992DTI TBSS L3 External capsule RGCST903845561.75e-03
9993Autoimmune diseases excluding thyroid diseasesFING000001321.74e-03
9994IntelligenceGCST901791141.74e-03
9995CD5 levelsGCST902747731.74e-03
9996THOP1 levelsGCST904708561.73e-03
9997Alcohol drinker status: current or former vs never (UKB data field 20117)GCST901329231.73e-03
9998Migraine without auraFING000008211.73e-03
9999TNFRSF11B levelsGCST902431581.72e-03
10000Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T48ECGU0000481.72e-03